Normocalcemic primary hyperparathyroidism is not associated with cardiometabolic alterations
Endocrine · 15.10.2024 · 86 (3) · 1140-1147
DOI: 10.1007/s12020-024-04063-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine, online erschienen am 15.10.2024. Verfasst von Marco Barale und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Oncological Endocrinology; Department of Medical Sciences, University of Turin, Turin, Italy. marco.barale@unito.it. Hauptthemen laut MEDLINE: Hyperparathyroidism, Primary, Cardiovascular Diseases, Blood Glucose. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Cardiometabolic disorders are non-classical complications of hypercalcemic primary hyperparathyroidism (HC-PHPT), but whether this risk connotes normocalcemic PHPT (NC-PHPT) remains to be elucidated. We investigated cardiometabolic alterations in both forms of PHPT, looking for their association with indices of disease activity.
Methods
Patients with HC-PHPT ( n = 17), NC-PHPT ( n = 17), and controls ( n = 34) matched for age, sex, and BMI were assessed for glucose, lipid, blood pressure alterations, and history of cardiovascular events to perform a case–control study at an ambulatory referral center for Bone Metabolism Diseases.
Results
NC-PHPT, in comparison to controls, showed similar glucose (mean ± SD, 88 ± 11 vs 95 ± 22 mg/dl), total cholesterol (199 ± 25 vs 207 ± 36 mg/dl), and systolic blood pressure levels (SBP, 132 ± 23 vs 132 ± 19 mmHg), together with a comparable frequency of glucose alterations (6% vs 9%), lipid disorders (41% vs 50%) and hypertension (53% vs 59%, p = NS for all comparisons). Conversely, all these abnormalities were more prevalent in HC-PHPT vs controls ( p < 0.05). When compared to NC-PHPT, HC-PHPT showed higher glucose (113 ± 31 mg/dl), total cholesterol (238 ± 43 mg/dl), and SBP levels (147 ± 15 mmHg) as well as an increased frequency of glucose (41%) and lipid alterations (77%) and a higher number of cardiovascular events (18% vs 0%, p < 0.05 for all comparisons). Among indices of PHPT activity, calcium levels displayed a significant correlation with glucose (R = 0.46) and SBP values (R = 0.60, p < 0.05).
Conclusion
NC-PHPT is not associated with cardiovascular alterations. The predominant pathogenetic role of hypercalcemia in the development of cardiometabolic disorders could account for the absence of such alterations in NC-PHPT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Oncological Endocrinology; Department of Medical Sciences, University of Turin, Turin, Italy. marco.barale@unito.it.
- Division of Endocrinology, Diabetes and Metabolism; Department of Medical Sciences, University of Turin, Turin, Italy.
- Division of Oncological Endocrinology; Department of Medical Sciences, University of Turin, Turin, Italy.
ORCID-Profile: Marco Barale
Zitieren
APA
Barale, M., Maiorino, F., Pusterla, A., Fraire, F., Sauro, L., Presti, M., Sagone, N., Ghigo, E., Arvat, E., & Procopio, M. (2024). Normocalcemic primary hyperparathyroidism is not associated with cardiometabolic alterations. Endocrine, 86(3), 1140-1147. https://doi.org/10.1007/s12020-024-04063-0
Vancouver
Barale M, Maiorino F, Pusterla A, Fraire F, Sauro L, Presti M, et al. Normocalcemic primary hyperparathyroidism is not associated with cardiometabolic alterations. Endocrine. 2024;86(3):1140-1147. doi:10.1007/s12020-024-04063-0
BibTeX
@article{Barale2024,
author = {Barale, Marco and Maiorino, Federica and Pusterla, Alessia and Fraire, Federica and Sauro, Lorenzo and Presti, Michela and Sagone, Noemi and Ghigo, Ezio and Arvat, Emanuela and Procopio, Massimo},
title = {Normocalcemic primary hyperparathyroidism is not associated with cardiometabolic alterations},
journal = {Endocrine},
year = {2024},
volume = {86},
number = {3},
pages = {1140--1147},
doi = {10.1007/s12020-024-04063-0}
}
EUVIMED